loading
Schlusskurs vom Vortag:
$8.56
Offen:
$8.58
24-Stunden-Volumen:
123.78K
Relative Volume:
0.79
Marktkapitalisierung:
$106.46M
Einnahmen:
$1.54M
Nettoeinkommen (Verlust:
$-38.70M
KGV:
-1.863
EPS:
-4.67
Netto-Cashflow:
$-36.86M
1W Leistung:
+7.94%
1M Leistung:
+5.58%
6M Leistung:
-23.35%
1J Leistung:
-85.07%
1-Tages-Spanne:
Value
$8.475
$8.935
1-Wochen-Bereich:
Value
$8.14
$9.2272
52-Wochen-Spanne:
Value
$4.64
$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
Firmenname
Corbus Pharmaceuticals Holdings Inc
Name
Telefon
617-963-0103
Name
Adresse
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
Mitarbeiter
28
Name
Twitter
@corbuspharma
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
CRBP's Discussions on Twitter

Vergleichen Sie CRBP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CRBP
Corbus Pharmaceuticals Holdings Inc
8.70 98.63M 1.54M -38.70M -36.86M -4.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-28 Eingeleitet William Blair Outperform
2024-12-02 Eingeleitet Piper Sandler Overweight
2024-07-30 Eingeleitet Wedbush Outperform
2024-07-22 Fortgesetzt H.C. Wainwright Buy
2024-06-26 Eingeleitet B. Riley Securities Buy
2024-06-03 Bestätigt Oppenheimer Outperform
2024-05-13 Eingeleitet RBC Capital Mkts Outperform
2024-03-06 Hochstufung Jefferies Hold → Buy
2020-09-08 Herabstufung BTIG Research Buy → Neutral
2020-09-08 Herabstufung Jefferies Buy → Hold
2020-09-08 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2020-09-08 Herabstufung ROTH Capital Buy → Neutral
2020-07-07 Eingeleitet ROTH Capital Buy
2020-06-17 Eingeleitet BTIG Research Buy
2020-03-26 Eingeleitet Nomura Buy
2019-04-05 Eingeleitet Jefferies Buy
2019-03-20 Eingeleitet Oppenheimer Outperform
2019-01-11 Bestätigt Cantor Fitzgerald Overweight
2018-12-26 Eingeleitet H.C. Wainwright Buy
2018-12-07 Eingeleitet RBC Capital Mkts Outperform
2018-10-24 Eingeleitet B. Riley FBR Buy
2018-01-19 Eingeleitet Raymond James Outperform
2017-12-14 Bestätigt Cantor Fitzgerald Overweight
2017-11-08 Bestätigt Noble Financial Buy
2017-09-29 Fortgesetzt Noble Financial Buy
2017-03-30 Bestätigt Cantor Fitzgerald Overweight
2016-11-15 Bestätigt JMP Securities Mkt Outperform
2016-11-11 Bestätigt Noble Financial Buy
Alle ansehen

Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten

pulisher
Jul 22, 2025

What drives Corbus Pharmaceuticals Holdings Inc. stock priceFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Corbus Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionElite Stock Shortlist - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Corbus Pharmaceuticals Holdings Inc. Stock Analysis and ForecastMarket-leading profit generation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Corbus Pharmaceuticals Holdings Inc. stockOutstanding yields - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Is Corbus Pharmaceuticals Holdings Inc. a good long term investmentOutstanding risk-reward balance - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is largely controlled by institutional shareholders who own 51% of the company - Yahoo Finance

Jul 20, 2025
pulisher
Jul 20, 2025

(CRBP) Proactive Strategies - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 18, 2025

why corbus pharmaceuticals holdings inc. stock attracts strong analyst attentionCapital Safe Stock Watchlist - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Corbus Pharmaceuticals Holdings Inc. stock price move sharplyPotential Rocket List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Corbus Pharmaceuticals Holdings Inc. stock performs during market volatilityLow Risk ROI Maximization - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

(CRBP) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 09, 2025

Bullish Sentiment Across The Cannabis SpaceCheck Full Movers For July 9, 2025 - Benzinga

Jul 09, 2025
pulisher
Jul 07, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Jul 07, 2025
pulisher
Jun 30, 2025

Corbus begins multiple ascending dose portion of CRB-913 obesity trial - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Corbus Pharmaceuticals Holdings, Inc.(NasdaqCM:CRBP) dropped from Russell Small Cap Completeness Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

How the (CRBP) price action is used to our Advantage - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 27, 2025

Cannabis Stock Movers For June 27, 2025 - Benzinga

Jun 27, 2025
pulisher
Jun 25, 2025

Corbus Cancer Drug Shows Promise: New Phase 1 Trial Combines Novel Nectin-4 ADC With Keytruda - Stock Titan

Jun 25, 2025
pulisher
Jun 24, 2025

Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium - GlobeNewswire

Jun 24, 2025
pulisher
Jun 17, 2025

Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data? - Seeking Alpha

Jun 17, 2025
pulisher
Jun 15, 2025

Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $50.88 - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Buys 7,207 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 13, 2025
pulisher
Jun 08, 2025

11,027 Shares in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Bought by Two Sigma Advisers LP - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

(CRBP) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Has $341,000 Stake in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Dermatomyositis Market Predicted to See Upsurge Through 2034, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Investments LP Purchases 91,205 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Deutsche Bank AG - Defense World

Jun 04, 2025
pulisher
May 29, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Millennium Management LLC - Defense World

May 29, 2025
pulisher
May 29, 2025

Northern Trust Corp Acquires 11,400 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 29, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Makes New Investment in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 27, 2025
pulisher
May 23, 2025

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies - Zacks Investment Research

May 23, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals CEO Set to Reveal Latest Corporate Strategy at Major Jefferies Healthcare Conference - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $50.88 Average Target Price from Analysts - Defense World

May 21, 2025
pulisher
May 20, 2025

Mizuho Securities Adjusts Corbus Pharmaceuticals Price Target to $32 From $42, Maintains Outperform Rating - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Mizuho Cuts Price Target on Corbus Pharmaceuticals Holdings to $32 From $42, Keeps Outperform Rating - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Cannabis Stock Movers For May 20, 2025 - Benzinga

May 20, 2025

Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):